Fig 1: eIF4A3 interacts with AIV PB2 and other subunits of viral polymerase in mammalian cells. (A) Schematic representation of BiFC analysis. Gray rectangle A and B represent a pair of proteins detected by BiFC. VN and VC represent the N-terminal fragment (residues 1–173) and C-terminal fragment (residues 174–239) of Venus protein, respectively. (B) BiFC assay for detecting interaction between PB2 and eIF4A3. HEK-293T cells were transiently transfected with indicated plasmids and incubated for 24 h. Fluorescence emission and brightfield were visualized. (C,D) Co-immunoprecipitation assays were performed with FLAG-tagged PB2 and Strep-tagged eIF4A3. Strep-tagged eIF4A3 or Strep-tagged empty vector was co-transfected in HEK-293T cells with Flag-tagged PB2 or Flag-tagged empty vector. After 24 h, cells were lysed followed by immunoprecipitation (IP) and western blot analyses. The arrow indicates the position of immunoblot. (E) The control vector, Flag-tagged PA, PB1, or NP expression constructs were individually transfected into HEK-293T cells along with Strep-eIF4A3 plasmid. After 24 h, cells were lysed followed by immunoprecipitation (IP) and western blot analyses.
Fig 2: eIF4A3 Is Important for Alyref Binding to Various RNAs and mRNA Export(A) RNA export factors average binding profiles at internal exon-exon junctions. EJC’s position is inferred from Figure S4A and marked by brown arrowheads.(B) Relative changes in Alyref RIP efficiency upon eIF4A3 RNAi in 293T cells. Mean of three independent experiments ± SD. ∗∗p < 0.01, ∗∗∗p < 0.001 (t test).(C) Examples of EJC bound to intronic (dashed boxes) or single-exon RNAs. Also see Figure S4C.(D) eIF4A3 and Alyref binding enrichments over Ctrl iCLIP on indicated RNA types and regions (as in Figure 1).(E) Oligo(dT) FISH on HeLa cells RNAi for the indicated factors. Pictures were taken at the same exposure level. White boxes indicate higher magnification. Scale bar, 10 μm. See also Figures S4 and S5.
Fig 3: EIF4A3 regulates RPL34‐AS1 expression. A and B, The binding sites of EIF4A3 were predicted in RPL34‐AS1 transcript using starBase. C, qRT‐PCR was used to detect the transcript abundance relative to input. D and E, Hela cells were transfected with control or EIF4A3 siRNA, and expression of EIF4A3 and RPL34‐AS1 was detected by qRT‐PCR. F and G, Siha cells were transfected with control or EIF4A3 overexpressing plasmid, and expression of EIF4A3 and RPL34‐AS1 was detected by qRT‐PCR. The data are presented as the mean ± SD, *P < .05, **P < .01, ****P < .0001
Fig 4: circ_0074027 is positively associated with EIF4A3. (A) Circular RNA Interactome analysis predicted genes that bound to circ_0074027. (B) circ_0074027 with EIF4A3 enrichment, which was measured using an RNA immunoprecipitation assay. (C) Gene expression of EIF4A3 profiled across tumor samples and tissues from normal patients, acquired from the Gene Expression Profiling Interactive Analysis database. (D) Expression of EIF4A3 was detected using RT-qPCR in gastric cancer cells following transfection. (E) Expression of EIF4A3 was detected using RT-qPCR in MKN45 cells following transfection with si-NC, si-circ-1 or si-circ-2. *P<0.05 and ***P<0.001 vs. GES-1 or siNC. RT-qPCR, reverse transcription-quantitative PCR; circ_0074027, circular RNA_0074927; sicirc, small interfering RNA of circ_0074027; si, small interfering RNA; NC, negative control; EIF4A3, eukaryotic translation initiation factor 4A3; STAD, stomach adenocarcinoma.
Fig 5: Reduced export of viral spliced mRNA in cells treated with eIF4A3 specific siRNA upon infection with AIV. A549 cells were treated with the NC (dark gray bars) or eIF4A3 (light gray bars) siRNAs for 36 h and subsequently infected with influenza virus V at an MOI of 5 for 4 h. Cytoplasmic and nuclear extracts were isolated and poly(A)+ mRNAs were purified. (A) The purity of the cytoplasmic and nuclear fractions was monitored by Western blot using antibodies specific for GAPDH or Histone H2B, respectively. (B) The levels of viral mRNA were quantified by RT-qPCR, normalized to 18srRNA. The data are shown as means ± SD (n = 3) and the significance was calculated using an unpaired t-test (*p < 0.05).
Supplier Page from Abcam for Anti-eIF4A3 antibody [EPR14301(B)]